Nath Bio-Genes (India) Limited (BOM:537291)

Market Cap	3.33B +10.2%
Revenue (ttm)	4.45B +21.9%
Net Income	416.30M +7.9%
EPS	20.98 +3.3%
Shares Out	n/a
PE Ratio	8.00
Forward PE	n/a
Dividend	2.00 (1.17%)
Ex-Dividend Date	Aug 14, 2025

Volume	2,421
Open	174.20
Previous Close	171.40
Day's Range	174.15 - 178.00
52-Week Range	126.75 - 238.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	May 4, 2026

About Nath Bio-Genes (India)

Nath Bio-Genes (India) Limited engages in the production, processing, and marketing of hybrid and GM seeds in India and internationally. It operates in two segments, Agricultural Activities and Trading Activities. The company offers fiber and oil seeds, including cotton and mustard; seeds for field crops, such as bajra, corn, paddy, wheat, and jowar; fruit seeds; and seeds for vegetables comprising cabbage, chilli, onion, okra, tomato, brinjal, bottle gourd, bitter gourd, sponge gourd, ridge gourd, cucumber, coriander, sweet pepper, green peas,...

• Industry: Agricultural Production Crops
• Founded: 1979
• Employees: 451
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 537291

Financial Performance

In fiscal year 2026, Nath Bio-Genes (India)'s revenue was 4.45 billion, an increase of 21.93% compared to the previous year's 3.65 billion. Earnings were 416.30 million, an increase of 7.85%.